Olatec Therapeutics’ Post

Olatec has been invited to present a scientific poster on dapansutrile, an #NLRP3inhibitor in clinical development in multiple diseases driven by inflammation at #EMBOinflammasomes24. The EMBO Workshop is bringing researchers together to advance inflammasome biology on September 24-27 in Germany. https://lnkd.in/eGKQUFx7

The inflammasomes - 2024

The inflammasomes - 2024

meetings.embo.org

Craig Basson

Chief Medical Officer

3mo

Great opportunity! Congrats.

Like
Reply

To view or add a comment, sign in

Explore topics